Sharechat Logo

Abano steps up pressure on bidders over audiology unit price

Tuesday 8th October 2013

Text too small?

Abano Healthcare, the specialist medical investor, is calling on a consortium mounting a hostile takeover bid to put a price on the audiology unit it plans to dump for a nominal value if the acquisition succeeds.

The healthcare firm's board has requested the bidders, made up of the company's biggest shareholder and former director Peter Hutson, Australian private equity firm Archer Capital and investor James Reeves, name how much Hutson would pay for Abano's half-stake in Bay International and are offering to buy him out at the same price. Abano valued its stake in the audiology business at $12.9 million as at May 31.

"Our offer to buy the 50 percent of Bay International we don't own, or sell the 50 percent we do own, at our option, at the price Peter Hutson wants to put on the business will be a further step in the removal of Hutson's conflicts of interest under the Archer proposal he has promoted," chairman Trevor Janes said in a statement. "If the Archer/Hutson/Reeves consortium is serious about making an offer for the company, they should do so."

Archer Capital, with Hutson, who owns about 15 percent of the specialist healthcare investor, have made an indicative offer of $6.97 a share, valuing Abano at $131.4 million. As part of the deal, an Archer-owned Abano would sell its audiology unit to Hutson for a nominal sum.

Abano's board rejected the initial indicative offer from Archer as being too low, and turned down its request for due diligence on the basis that the private equity firm will likely become a competitor.

If it buys out Hutson's stake in Bay International, it will proceed with its audiology strategy and put forward a full range of options to all shareholders, Janes said.

Hutson resigned from the board last month after his fellow directors urged him to do so, saying he was conflicted by his involvement in the takeover bid.

The shares slipped 0.1 percent to $6.84 yesterday, and have gained to 10 percent this year. The stock is rated an average 'buy' based on two analyst recommendations compiled by Reuters, with a median target price of $7.21.

NOTE: please be advised to read full articles from Business Desk Website, you will have to pay a subscription fee on their website.

BusinessDesk.co.nz



  General Finance Advertising    

Comments from our readers

No comments yet

Add your comment:
Your name:
Your email:
Not displayed to the public
Comment:
Comments to Sharechat go through an approval process. Comments which are defamatory, abusive or in some way deemed inappropriate will not be approved. It is allowable to use some form of non-de-plume for your name, however we recommend real email addresses are used. Comments from free email addresses such as Gmail, Yahoo, Hotmail, etc may not be approved.

Related News:

Abano mulls rebel shareholder request for meeting, affirms support for Janes
Hutson fails to respond to Abano buyout offer, takeover 'rife with insider elements'
Abano shareholders clamour for discounted stock in share purchase plan
Hutson quits Abano board after urging from other directors
Abano board questions Hutson's conflict of interest in takeover bid
Abano continues to resist takeovers, rejects approach from Archer, Hutson
Abano seeks $18.5 mln in share purchase plan
Abano shares climb to 4-month high amid prospect of takeover bid
Abano faces takeover bid after rejecting unsolicited offer
Abano reports 75 percent NPAT uplift to $2.8 mln on $207 mln turnover

IRG See IRG research reports